German Measles RUBELLA IGM

The Rubella IgM test detects IgM antibodies produced in response to recent infection with the rubella (German measles) virus by analysing a blood sample—collected at home by a trained phlebotomist—and uses validated immunoassays to indicate acute or recent exposure. It is recommended for symptomatic individuals, contact or outbreak screening, and critically for pregnant women or those planning pregnancy because maternal infection can cause congenital rubella; at-home collection and secure laboratory processing are available across Dubai and the UAE. Results are processed rapidly (typically within 24–48 hours), but positive IgM findings require confirmatory testing and immediate clinical consultation—do not self-medicate and present results to your physician or antenatal clinic for appropriate follow-up.

• Rubella IgM antibody (Qualitative)
• Rubella IgM antibody concentration (IU/mL, Quantitative)
• Sample type: Venous blood / Capillary (finger‑prick)
• Collection: Home phlebotomy by certified technician (Dubai & UAE)
• Result interpretation: Recent infection vs. no recent infection

• Detects recent/acute Rubella infection by measuring Rubella IgM antibodies from a blood sample
• At-home sample collection by trained phlebotomists available across Dubai and the UAE
• Rapid lab turnaround with secure digital results and clear interpretation (typically same-day or 24–48 hours)
• Recommended for pregnant women or preconception screening to assess risk of congenital rubella
• Performed in UAE-accredited laboratories using validated immunoassays with follow-up care guidance

• Detects Rubella-specific IgM antibodies indicating recent or acute infection
• At-home blood collection by trained phlebotomists across Dubai and the UAE
• Processed in UAE-accredited laboratories with fast turnaround and secure digital report
• Essential screening after suspected exposure or during pregnancy to guide timely clinical follow-up
• Confidential results with clinician interpretation available on request; compliant with UAE healthcare standards

• At‑home venous blood collection by certified phlebotomists for Rubella IgM serology
• Detects recent/acute Rubella infection (IgM antibodies) to assess exposure risk, especially in pregnancy
• Processed in DHA‑accredited UAE laboratories using validated immunoassays; electronic results in 24–48 hours
• Positive or equivocal results include confirmatory testing and clinician follow‑up with DHA‑compliant reporting support